Helicobacter Pylori Eradication Within 120 Days Is Associated with Decreased Complicated Recurrent Peptic Ulcers in Peptic Ulcer Bleeding Patients

Overview

Journal Gut Liver

Specialty Gastroenterology

Date 2014 Aug 30

PMID 25167793

Citations 6

Authors

Shen Shong Chang

Hsiao-Yun Hu

Affiliations

Soon will be listed here.

Abstract

Background/aims: The connection between Helicobacter pylori and complicated peptic ulcer disease in peptic ulcer bleeding (PUB) patients taking nonsteroidal anti-inflammatory drugs has not been established. In this study, we sought to determine whether delayed H. pylori eradication therapy in PUB patients increases complicated recurrent peptic ulcers.

Methods: We identified inpatient PUB patients using the Taiwan National Health Insurance Research Database. We categorized patients into early (time lag ≤120 days after peptic ulcer diagnosis) and late H. pylori eradication therapy groups. The Cox proportional hazards model was used. The primary outcome was rehospitalization for patients with complicated recurrent peptic ulcers.

Results: Our data indicated that the late H. pylori eradication therapy group had a higher rate of complicated recurrent peptic ulcers (hazard ratio [HR], 1.52; p=0.006), with time lags of more than 120 days. However, our results indicated a similar risk of complicated recurrent peptic ulcers (HR, 1.20; p=0.275) in time lags of more than 1 year and (HR, 1.10; p=0.621) more than 2 years.

Conclusions: H. pylori eradication within 120 days was associated with decreased complicated recurrent peptic ulcers in patients with PUB. We recommend that H. pylori eradication should be conducted within 120 days in patients with PUB.

Citing Articles

Risk factors for peptic ulcer bleeding one year after the initial episode.

Peng Y, Chang W Gut Pathog. 2024; 16(1):71.

PMID: 39609846 PMC: 11606131. DOI: 10.1186/s13099-024-00669-x.

An update on the management of non-variceal upper gastrointestinal bleeding.

Alali A, Barkun A Gastroenterol Rep (Oxf). 2023; 11:goad011.

PMID: 36949934 PMC: 10027415. DOI: 10.1093/gastro/goad011.

Impact of eradication timing on the risk of thromboembolism events in patients with peptic ulcer disease: a population-based cohort study.

Lai J, Liao Y, Lin C, Chang C, Peng Y BMJ Open. 2022; 12(8):e060361.

PMID: 36002209 PMC: 9413183. DOI: 10.1136/bmjopen-2021-060361.

Early Diagnosis of Infection in Vietnamese Patients with Acute Peptic Ulcer Bleeding: A Prospective Study.

Quach D, Luu M, Hiyama T, To T, Bui Q, Tran T Gastroenterol Res Pract. 2017; 2017:3845067.

PMID: 28133477 PMC: 5241452. DOI: 10.1155/2017/3845067.

There Is No Reason to Delay Helicobacter pylori Eradication after Treatment for Upper Gastrointestinal Bleeding.

Lee S Gut Liver. 2015; 9(3):259-60.

PMID: 25918256 PMC: 4413960. DOI: 10.5009/gnl14499.

References

. Technical annex: tests used to assess Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. Gut. 1997; 41 Suppl 2:S10-8. View

Gisbert J, Abraira V . Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol. 2006; 101(4):848-63. DOI: 10.1111/j.1572-0241.2006.00528.x. View

Liou J, Chen C, Chen M, Chen C, Chang C, Fang Y . Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet. 2012; 381(9862):205-13. DOI: 10.1016/S0140-6736(12)61579-7. View

Tseng G, Lin H, Fang C, Yang H, Tseng G, Wang P . Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study. Aliment Pharmacol Ther. 2007; 26(6):925-33. DOI: 10.1111/j.1365-2036.2007.03438.x. View

Bianchi Porro G, Lazzaroni M . The conflicting relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding. Scand J Gastroenterol. 1999; 34(3):225-8. DOI: 10.1080/00365529950173591. View

Chang S, Hu H . Helicobacter pylori is not the predominant etiology for liver cirrhosis patients with peptic ulcer disease. Eur J Gastroenterol Hepatol. 2012; 25(2):159-65. DOI: 10.1097/MEG.0b013e32835a1b26. View

Cheng S, Chiang T . The effect of universal health insurance on health care utilization in Taiwan. Results from a natural experiment. JAMA. 1997; 278(2):89-93. DOI: 10.1001/jama.278.2.89. View

. Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. Gut. 1997; 41 Suppl 2:S1-9. View

Chan F, Sung J, Chung S, To K, Yung M, Leung V . Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet. 1997; 350(9083):975-9. DOI: 10.1016/s0140-6736(97)04523-6. View

10.

Laine L, PETERSON W . Bleeding peptic ulcer. N Engl J Med. 1994; 331(11):717-27. DOI: 10.1056/NEJM199409153311107. View

11.

Kang J, Ho K, Yeoh K, Guan R, Wee A, Lee E . Peptic ulcer and gastritis in uraemia, with particular reference to the effect of Helicobacter pylori infection. J Gastroenterol Hepatol. 1999; 14(8):771-8. DOI: 10.1046/j.1440-1746.1999.01947.x. View

12.

Nozaki K, Shimizu N, Ikehara Y, Inoue M, Tsukamoto T, Inada K . Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci. 2003; 94(3):235-9. PMC: 11160175. DOI: 10.1111/j.1349-7006.2003.tb01426.x. View

13.

Cameron E, Bell G, Baldwin L, Powell K, Williams S . Long-term study of re-infection following successful eradication of Helicobacter pylori infection. Aliment Pharmacol Ther. 2006; 23(9):1355-8. DOI: 10.1111/j.1365-2036.2006.02899.x. View

14.

Wu C, Kuo K, Wu M, Chen Y, Wang C, Lin J . Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology. 2009; 137(5):1641-8.e1-2. DOI: 10.1053/j.gastro.2009.07.060. View

15.

Lee J, Breslin N, Fallon C, OMorain C . Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding. Am J Gastroenterol. 2000; 95(5):1166-70. DOI: 10.1111/j.1572-0241.2000.02004.x. View

16.

Chen T, Luo J, Chang F . Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan. J Gastroenterol Hepatol. 2010; 25(5):919-22. DOI: 10.1111/j.1440-1746.2009.06139.x. View

17.

. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA. 1994; 272(1):65-9. View

18.

Hermansson M, Ekedahl A, Ranstam J, Zilling T . Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002. BMC Gastroenterol. 2009; 9:25. PMC: 2679757. DOI: 10.1186/1471-230X-9-25. View

19.

Hippisley-Cox J, Coupland C, Logan R . Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ. 2005; 331(7528):1310-6. PMC: 1298853. DOI: 10.1136/bmj.331.7528.1310. View

20.

Sanchez-Delgado J, Gene E, Suarez D, Garcia-Iglesias P, Brullet E, Gallach M . Has H. pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression. Am J Gastroenterol. 2011; 106(3):398-405. DOI: 10.1038/ajg.2011.2. View